K E Leslie Selected Research

flunixin meglumine (Banamine)

1/2017	The effects of periparturient administration of flunixin meglumine on the health and production of dairy cattle.
5/2013	Short communication: experimentally induced mastitis reduces weight shifting between the rear legs while standing in dairy cows.
9/2012	The effects of experimentally induced Escherichia coli mastitis and flunixin meglumine administration on activity measures, feed intake, and milk parameters.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

K E Leslie Research Topics

Disease

12	Mastitis 02/2016 - 01/2003
6	Infections 10/2012 - 12/2002
4	Diarrhea 09/2018 - 05/2005
4	Retained Placenta 10/2012 - 03/2004
4	Endometritis 04/2012 - 09/2002
3	Body Weight (Weight, Body) 11/2018 - 05/2013
3	Pain (Aches) 01/2017 - 05/2013
2	Dystocia 09/2012 - 12/2010
2	Vaginitis 03/2007 - 03/2007
1	Infectious Bovine Rhinotracheitis 09/2018
1	Paramyxoviridae Infections (Parainfluenza) 09/2018
1	Pneumonia (Pneumonitis) 09/2018
1	Stillbirth 01/2017
1	Edema (Dropsy) 05/2013
1	Inflammation (Inflammations) 05/2013
1	Weight Gain 01/2013
1	Anovulation 04/2012
1	Cryptosporidiosis 05/2011
1	Vaginal Discharge 03/2011
1	Uterine Diseases (Endometrial Disease) 03/2011
1	Ketosis 09/2007
1	Fatty Liver 09/2007
1	Staphylococcal Infections 01/2003

Drug/Important Bio-Agent (IBA)

6	Anti-Bacterial Agents (Antibiotics)IBA 10/2012 - 09/2002
3	Meloxicam (Mobic)FDA LinkGeneric 11/2018 - 06/2010
3	VaccinesIBA 09/2018 - 01/2005
3	flunixin meglumine (Banamine)IBA 01/2017 - 09/2012
3	CoagulaseIBA 02/2016 - 06/2006
3	LipopolysaccharidesIBA 05/2013 - 05/2012
3	Pharmaceutical PreparationsIBA 05/2013 - 09/2012
3	Nonesterified Fatty Acids (NEFA)IBA 10/2012 - 01/2005
2	EndotoxinsIBA 05/2013 - 05/2013
2	halofuginoneIBA 05/2011 - 05/2005
2	Fatty Acids (Saturated Fatty Acids)IBA 12/2010 - 03/2004
2	CloprostenolIBA 02/2005 - 09/2002
2	Cephapirin (Cefapirin)FDA Link 02/2005 - 09/2002
2	tilmicosinIBA 01/2003 - 12/2002
1	Capsules (Microcapsules)IBA 11/2018
1	AntigensIBA 09/2018
1	Analgesics (Analgesic Drugs)IBA 01/2017
1	Butyrates (Butyrate)IBA 09/2016
1	Volatile Fatty AcidsIBA 09/2016
1	Saline SolutionIBA 05/2013
1	Indicators and Reagents (Reagents)IBA 10/2012
1	CalciumIBA 10/2012
1	AcidsIBA 10/2012
1	Prostaglandins FIBA 03/2011
1	SolutionsIBA 06/2010
1	isoflupredone acetateIBA 09/2007
1	Insulin (Novolin)FDA Link 09/2007
1	GlucocorticoidsIBA 09/2007
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 09/2006
1	Whey ProteinsIBA 08/2006
1	VitaminsIBA 03/2004
1	alpha-Tocopherol FDA Link 03/2004
1	Vitamin A (Retinol)FDA LinkGeneric 03/2004
1	Proteins (Proteins, Gene)FDA Link 01/2003
1	Phosphates (Orthophosphate)IBA 12/2002
1	benzathineIBA 09/2002
1	DinoprostIBA 09/2002

Therapy/Procedure

3	Therapeutics 06/2010 - 06/2006
2	Injections 09/2018 - 10/2012
2	Device Removal (Removal, Device) 03/2007 - 03/2007
2	Phage Therapy 09/2006 - 08/2006
1	Analgesia 05/2013
1	Activities of Daily Living (ADL) 01/2013
1	Off-Label Use 10/2012
1	Drug Therapy (Chemotherapy) 06/2010
1	Subcutaneous Injections 06/2010
1	Aftercare (After-Treatment) 09/2007